OC7 AN IL28B POLYMORPHISM PREDICTS PEGYLATED INTERFERON PLUS RIBAVIRIN TREATMENT OUTCOME IN CHRONIC HEPATITIS C GENOTYPE 4
Stella De Nicola(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), M. Colombo(University of Milan), Cristina Cheroni(Human Technopole), Raffaele De Francesco(University of Milan), Maria Francesca Donato(University of Milan), Luca Valenti(University of Milan), E. Galmozzi(University of Milan), Roberta D’Ambrosio(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Alessio Aghemo, Maria Grazia Rumi(University of Milan), G.M. Prati(University of Milan), R. Soffredini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)
Cited by 10
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Global patterns of hepatocellular carcinoma management from diagnosis to death: the <scp>BRIDGE</scp> Study
|Liver International|2015|1.3k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Annals of Hepatology|2023|789